Alembic’s Bimatoprost gets USFDA approval

Pharma/BioPharma |  News | 0 Comment | 23 Apr, 2019

Alembic Pharmaceuticals Limited recently announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) ...Read more

TB Alliance, Mylan to commercialize pretomanid to treat TB

Pharma/BioPharma |  News | 0 Comment | 23 Apr, 2019

Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. have announced a global collaboration to make the experimental drug pretomanid accessible for use in two inves...Read more

Lupin gets FDA nod for Fluoxetine Tablets USP

Pharma/BioPharma |  News | 0 Comment | 22 Apr, 2019

Pharma major Lupin Limited (Lupin) announced that it has received approval for its Fluoxetine Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (FDA) to mark...Read more

India to be one of the world’s ‘fastest growing bio’ hubs in 2019: CPhI data

Pharma/BioPharma |  News | 0 Comment | 18 Apr, 2019

New data from CPhI shows that, despite ongoing reputational challenges, India’s biologics market is set for robust growth in 2019 driven by biosimilars production. The India spe...Read more

Merck launches drug compound to treat and prevent Folate deficiencies

Pharma/BioPharma |  News | 0 Comment | 18 Apr, 2019

Merck has launched a new and improved proprietary product: Arcofolin™ L-Methylfolate, a monosodium salt of L-5-methyltetrahydrofolic acid for nutritional and pharmaceutical appli...Read more

Zydus Cadila announces phase III trial of Desidustat

Pharma/BioPharma |  News | 0 Comment | 17 Apr, 2019

Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Investigational New Drug targeted at treating anemia in non-dialysis depe...Read more

Suven receives court approval to buy assets of Rising Pharmaceuticals

Pharma/BioPharma |  News | 0 Comment | 15 Apr, 2019

Suven Life Sciences Limited, a biopharmaceutical company provider of Contract Research and Manufacturing Services (CRAMS) for global life science companies, has received the US Bankruptcy C...Read more

Dr. Reddy's announces acquisition of ANDA portfolio

Pharma/BioPharma |  News | 0 Comment | 15 Apr, 2019

Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s” has entered into a definitive agreement to acquire a portfolio of 42...Read more

Wockhardt receives US FDA approval for cancer drug

Pharma/BioPharma |  News | 0 Comment | 11 Apr, 2019

Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, whic...Read more

Vanta Bioscience signs Rs 29 Cr deal with Emcure Pharma

Pharma/BioPharma |  News | 0 Comment | 09 Apr, 2019

Vanta Bioscience Limited has announced that its step-down subsidiary ‘Vayam Research Solutions Limited’ has entered into a non-exclusive CRO Service Agreement with Emcure Pharma...Read more

Sun Pharma launches ready-to-infuse INFUGEM in the US

Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

Sun Pharmaceutical Industries Ltd. has announced that INFUGEM™ (gemcitabine in sodium chloride injection), for intravenous use, is now commercially available in the U.S. INFUGEM, the ...Read more

Everstone to sell controlling stake in Rubicon Research

Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

Everstone is a premier investment group focused on India and South East Asia. Everstone Group’s Singapore fund, will sell its entire stake in Rubicon Research (Rubicon) to a global pr...Read more

Olon completes acquisition of Mahad plant

Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

OlonS.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has announced the closing of the acquis...Read more

Lupin launches Tadalafil Tablets USP

Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

Lupin has announced the launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupi...Read more

Dr. Reddy’s announces US rights for its dermatology brands

Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

Dr. Reddy’s Laboratories Limited, through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0...Read more

Pulmatrix signs binding agreement with Cipla worth $22M

Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, has announced its entry into a Bind...Read more

Novartis to acquire IFM Tre in a $310M deal

Pharma/BioPharma |  News | 0 Comment | 01 Apr, 2019

IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that it has reached a d...Read more

Lupin launches Fluocinonide Ointment USP 0.05%

Pharma/BioPharma |  News | 0 Comment | 29 Mar, 2019

Lupin announced the launch of Fluocinonide Ointment USP, 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Fluocinonide Oi...Read more